Pathogenesis of 5q- syndrome
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F16%3A00011653" target="_blank" >RIV/00023736:_____/16:00011653 - isvavai.cz</a>
Result on the web
<a href="https://www.novapublishers.com/catalog/product_info.php?products_id=56830&osCsid=bcdf867f385e9f4704bf0d72cae76d60" target="_blank" >https://www.novapublishers.com/catalog/product_info.php?products_id=56830&osCsid=bcdf867f385e9f4704bf0d72cae76d60</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Pathogenesis of 5q- syndrome
Original language description
Myelodysplastic syndrome (MDS) is a family of clonal haematopoietic stem cells disorders characterized by dysplasia, ineffective hematopoiesis and susceptibility to transformation to Acute Myeloblastic Leukaemia (AML) that are shown to be strikingly refractory to current therapeutic modalities.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NT13836" target="_blank" >NT13836: The study of the myelodysplastic syndrome pathogenesis in patients with isolated del(5q) abnormality and the analysis of the effect of lenalidomide</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Myelodysplastic syndromes (MDS): risk factors, treatment and prognosis
ISBN
978-1-63484-330-0
Number of pages of the result
35
Pages from-to
51-85
Number of pages of the book
254
Publisher name
Niova Science
Place of publication
New York
UT code for WoS chapter
—